LETTER
Synthesis of Sugar Iminopyrrolidine Derivatives
1877
H2N
O
H
H
O
O
H2N
HO
N3
NC
HN
O
O
O
O
O
O
N
O
19
O
O
O
HN
HN
iii
ii
i
HO
H2N
O
O
O
1
O
O
O
HO
HO
HO
O
O
O
20
21
22
Scheme 3 Reagents and conditions: (i) a) 19, Ti(Oi-Pr)4, MeOH, b) TMSCN; (ii) a) PPh3, THF, b) NH3–MeOH; (iii) H2O–NaOH (2 N),
reflux; then IRA-120.
M.; Humes, J. L.; Pacholok, S. G.; Kelly, T. M.; Grant, S. K.;
Wong, K. K. Bioorg. Med. Chem. Lett. 2004, 14, 5907.
(c) Gadreau, C.; Foucaud, A. Tetrahedron Lett. 1974, 48,
4243.
In conclusion we reported the first example of a
Staudinger–aza-Wittig reaction on a furanoside, which
gave a convenient access to fused iminopyrrolidines in
good yields. Further experiments are in progress to ex-
plore the influences of the substituent in the a-position re-
garding the electronic effect and the hard and soft balance
between the N-nucleophilic center of the iminophospho-
rane and C-electrophilic center of the cyano group.
(9) Benati, L.; Bencivenni, G.; Leardini, R.; Minozzi, M.;
Nanni, D.; Scialpi, R.; Spagnolo, P.; Zanardi, G.; Rizzoli, C.
Org. Lett. 2004, 6, 417.
(10) (a) Postel, D.; Nguyen Van Nhien, A.; Pillon, M.; Villa, P.;
Ronco, G. Tetrahedron Lett. 2000, 41, 6403. (b) Nguyen
Van Nhien, A.; Ducatel, H.; Len, C.; Postel, D. Tetrahedron
Lett. 2002, 43, 3805. (c) Postel, D.; Nguyen Van Nhien, A.;
Marco, J. L. Eur. J. Org. Chem. 2003, 19, 3713.
(d) Dominguez, L.; Nguyen Van Nhien, A.; Tomassi, C.;
Len, C.; Postel, D.; Marco-Contelles, J. L. J. Org. Chem.
2004, 69, 843. (e) Nguyen Van Nhien, A.; Tomassi, C.; Len,
C.; Marco-Contelles, J. L.; Balzarini, J.; Pannecouque, C.;
De Clercq, E.; Postel, D. J. Med. Chem. 2005, 48, 4276.
(11) Ewing, D. F.; Goethals, G.; MacKenzie, G.; Martin, P.;
Ronco, G.; Vanbaelinghem, L.; Villa, P. Carbohydr. Res.
1999, 321, 190.
Acknowledgment
The authors thank the Conseil Régional de Picardie and the Mini-
stère Français de la Recherche for supporting this work and to G.
Mackenzie for helpful discussions, and careful revision of the
manuscript.
References and Notes
(12) (1R,3R,4R,5R)-5,6-Diamino-3,4-O-isopropylidene-7-aza-
2-oxabicyclo[3.3.0]oct-6-ene (8).
(1) Moncada, S.; Higgs, E. A. FASEB J. 1995, 9, 1319.
(2) Knowles, R. G.; Moncada, S. Biochem. J. 1994, 298, 249.
(3) Kawanaka, Y.; Kobayashi, K.; Kusuda, S.; Tatsumi, T.;
Murot, M.; Nishiyama, T.; Hisaichi, K.; Fujii, A.; Hirai, K.;
Nak, M.; Komeno, M.; Odagaki, Y.; Nakai, H.; Toda, M.
Bioorg. Med. Chem. Lett. 2003, 13, 1723; and references
cited therein.
(4) (a) Ueda, S.; Terauchi, H.; Yano, A.; Iro, M.; Matsumoto,
M.; Kawasaki, M. Bioorg. Med. Chem. Lett. 2004, 14, 313.
(b) Atkinson, R. N.; Moore, L.; Tobin, J.; King, S. B. J. Org.
Chem. 1999, 64, 3467.
(5) Moore, W. M.; Webber, R. K.; Fok, K. F.; Jerome, G. M.;
Connor, J. R.; Manning, P. T.; Wyatt, P. S.; Misko, T. P.;
Tjoeng, F. S.; Currie, M. G. J. Med. Chem. 1996, 39, 669.
(6) (a) Hagen, T. J.; Bergmanis, A. A.; Kramer, S. W.; Fok, K.
F.; Schmelzer, A. E.; Pitzele, B. S.; Swenton, L.; Jerome, G.
M.; Kornmeier, C. M.; Moore, W. M.; Branson, L. F.;
Connor, J. R.; Manning, P. T.; Currie, M. G.; Hallinan, E. A.
J. Med. Chem. 1998, 41, 3675. (b) Tsymbalov, S.; Hagen,
T. J.; Moore, W. M.; Jerome, G. M.; Connor, J. R.; Manning,
P. T.; Pitzele, B. S.; Hallinan, E. A. Bioorg. Med. Chem. Lett.
2002, 12, 3337. (c) Guthikonda, N. R.; Shah, S. K.;
Pacholok, S. G.; Humes, J. L.; Mumford, R. A.; Grant, S. K.;
Chabin, R. M.; Green, B. G.; Tsou, N.; Ball, R.; Fletcher, D.
S.; Luell, S.; MacIntyre, D. E.; MacCoss, M. Bioorg. Med.
Chem. Lett. 2005, 15, 1997.
To a solution of compound 2 (0.20 g, 0.85 mmol) in 10 mL
of THF–H2O (4:1) was added 0.25 g (0.93 mmol) of PPh3.
After stirring overnight at r.t., the reaction mixture was
evaporated and extracted with Et2O and H2O. The aqueous
layer was evaporated to give 0.16 g (89%) of 8 as a slight
yellow syrup; [a]D20 20 (c 0.17, CHCl3). IR (ATR): 2988,
1655, 1374, 1217, 1165, 1086, 1007, 877, 733 cm–1. 1H
NMR (CDCl3): d = 5.80 (d, 1 H, H-1, J1,2 = 3.9 Hz), 4.60 (d,
1 H, H-2), 4.30 (d, 1 H, H-4, J4,5a = 3.0 Hz), 3.72 (dd, 1 H,
H-5a, J5a,5b = 14.0 Hz), 3.67 (d, 1 H, H-5b), 1.53 (s, 3 H,
CH3), 1.35 (s, 3 H, CH3). 13C NMR (CDCl3): d = 168.2
(C=N), 112.9 (CH3CCH3), 106.1 (C-1), 85.1 (C-4), 82.2
(C-2), 74.1 (C-3), 55.5 (C-5), 27.6, 27.3 (2 × CH3). HRMS:
m/z calcd for C9H16N3O3 [M + H]+: 214.1192; found:
214.1196. Anal. Calcd for C9H15N3O3: C, 50.69; H, 7.09; N,
19.71. Found: C, 50.54; H, 6.95; N, 19.60.
(13) Key Data for Compound 9.
13C NMR (CDCl3): d = 173.4 (C=N, J2C-P = 9.0 Hz), 75.4
(C-3, J3C-P = 17.2 Hz), 14.4 [P(CH3)3, J1CH3-P = 66.0 Hz).
MS: m/z = 288.14 [M + H]+.
(14) 3-Amino-3-deoxy-1,2-O-isopropylidene-a-D-ribofurano-
sidurono-3,5-lactam (17).
White solid, mp 159–162 °C; [a]D20 18 (c 0.11, CHCl3). 1H
NMR (CD3OD): d = 5.81 (d, 1 H, H-1, J1,2 = 3.9 Hz), 4.60
(d, 1 H, H-2), 4.40 (d, 1 H, H-4, J4,5a = 3.5 Hz), 3.65 (dd, 1
H, H-5a, J5a,5b = 11.8 Hz), 3.32 (d, 1 H, H-5b), 1.56 (s, 3 H,
CH3), 1.38 (s, 3 H, CH3). 13C NMR (CD3OD): d = 176.4 (1
C, C=O), 112.8 (1 C, CH3CCH3), 106.1 (1 C, C-1), 81.9 (1
C, C-2), 81.8 (1 C, C-4), 68.8 (1 C, C-3), 45.6 (1 C, C-5),
26.4, 26.0 (2 C, CH3). IR (ATR): n = 2959, 2932, 1716,
1659, 1465, 1382, 1233, 1166, 1098, 1082, 1001 cm–1.
HRMS: m/z calcd for C9H14N2O4Na: 237.0851 [M + Na]+;
found: 237.0850.
(7) Burden, P. M. Synth. Commun. 1993, 23, 1195.
(8) (a) Shankaran, K.; Donnelly, K.; Shah, S. K.; Guthikonda, R.
N.; MacCoss, M.; Humes, J. L.; Pacholok, S. G.; Grant, S.
K.; Kelly, T. M.; Wong, K. K. Bioorg. Med. Chem. Lett.
2004, 14, 4539. (b) Shankaran, K.; Donnelly, K. L.; Shah, S.
K.; Caldwell, C. G.; Chen, P.; Hagmann, W. K.; MacCoss,
Synlett 2006, No. 12, 1875–1878 © Thieme Stuttgart · New York